Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

[Rituximab in antiphospholipid syndrome: Always, never, sometimes?]

Ugarte A, Ruiz Irastorza G.

Med Clin (Barc). 2014 Aug 19. pii: S0025-7753(14)00363-7. doi: 10.1016/j.medcli.2014.04.014. [Epub ahead of print] Spanish. No abstract available.

PMID:
25148947
[PubMed - as supplied by publisher]
2.

Anti-C1q antibodies in systemic lupus erythematosus.

Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón G, Gordon C, Merrill J, Fortin P, Bruce I, Isenberg D, Wallace D, Ramsey-Goldman R, Bae SC, Hanly J, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth V, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta M, Jacobsen S, Buyon J, Maddison P, Dooley M, Van Vollenhoven R, Ginzler E, Stoll T, Peschken C, Jorizzo J, Callen J, Lim S, Fessler B, Inanc M, Kamen D, Rahman A, Steinsson K, Franks A Jr, Sigler L, Hameed S, Pham N, Brey R, Weisman M, McGwin G Jr, Magder L, Petri M.

Lupus. 2014 Aug 14. pii: 0961203314547791. [Epub ahead of print]

PMID:
25124676
[PubMed - as supplied by publisher]
3.

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Petri M, Steinsson K, Dooley MA, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Urowitz MB.

Ann Rheum Dis. 2014 May 16. pii: annrheumdis-2013-205171. doi: 10.1136/annrheumdis-2013-205171. [Epub ahead of print]

PMID:
24834926
[PubMed - as supplied by publisher]
Free Article
4.

Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.

Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim SS, Kamen DL, Peschken CA, Inanc M, Bruce IN.

Ann Rheum Dis. 2014 Apr 1. doi: 10.1136/annrheumdis-2013-203933. [Epub ahead of print]

PMID:
24692585
[PubMed - as supplied by publisher]
Free Article
5.

Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.

Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G.

Rheumatology (Oxford). 2014 Aug;53(8):1470-6. doi: 10.1093/rheumatology/keu148. Epub 2014 Mar 27.

PMID:
24681836
[PubMed - indexed for MEDLINE]
6.

Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.

Gonzalez-Echavarri C, Pernas B, Ugarte A, Ruiz-Irastorza G.

Lupus. 2014 Mar;23(3):323-6. doi: 10.1177/0961203314520842.

PMID:
24531426
[PubMed - in process]
7.

Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors.

Erdozain JG, Villar I, Nieto J, Ruiz-Irastorza G.

J Rheumatol. 2014 Feb;41(2):310-7. doi: 10.3899/jrheum.130817. Epub 2014 Jan 15.

PMID:
24429176
[PubMed - in process]
8.

Prednisone in lupus nephritis: how much is enough?

Ruiz-Irastorza G, Danza A, Perales I, Villar I, Garcia M, Delgado S, Khamashta M.

Autoimmun Rev. 2014 Feb;13(2):206-14. doi: 10.1016/j.autrev.2013.10.013. Epub 2013 Nov 2.

PMID:
24189280
[PubMed - indexed for MEDLINE]
9.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, Fortin PR, Gladman DD, Fessler BJ, Alarcón GS, Bruce IN, Dooley MA, Steinsson K, Khamashta MA, Ramsey-Goldman R, Manzi S, Sturfelt GK, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Aranow C, Mackay M, Ruiz-Irastorza G, Kalunian KC, Lim SS, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Theriault C, Thompson K, Farewell V.

Arthritis Rheum. 2013 Nov;65(11):2887-97. doi: 10.1002/art.38106. Erratum in: Arthritis Rheum. 2014 Jun;66(6):1671.

PMID:
24166793
[PubMed - indexed for MEDLINE]
10.

Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.

Danza A, Ruiz-Irastorza G.

Lupus. 2013 Oct;22(12):1286-94. doi: 10.1177/0961203313493032. Review.

PMID:
24098001
[PubMed - indexed for MEDLINE]
11.

Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).

Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L, Gordon C, Ruiz-Irastorza G, Egurbide MV, Gil A, Espinosa G, Houssiau F, Rahman A, Martin H, McHugh N, Galindo M, Akil M, Amigo MC, Murru V, Khamashta MA.

Rheumatology (Oxford). 2014 Feb;53(2):275-84. doi: 10.1093/rheumatology/ket313. Epub 2013 Oct 4.

PMID:
24097288
[PubMed - indexed for MEDLINE]
12.

Breast cancer in systemic lupus erythematosus.

Tessier Cloutier B, Clarke AE, Ramsey-Goldman R, Wang Y, Foulkes W, Gordon C, Hansen JE, Yelin E, Urowitz MB, Gladman D, Fortin PR, Wallace DJ, Petri M, Manzi S, Ginzler EM, Labrecque J, Edworthy S, Dooley MA, Senécal JL, Peschken CA, Bae SC, Isenberg D, Rahman A, Ruiz-Irastorza G, Hanly JG, Jacobsen S, Nived O, Witte T, Criswell LA, Barr SG, Dreyer L, Sturfelt G, Bernatsky S.

Oncology. 2013;85(2):117-21. doi: 10.1159/000353138. Epub 2013 Jul 25.

PMID:
23887245
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.

Ochoa E, Iriondo M, Bielsa A, Ruiz-Irastorza G, Estonba A, Zubiaga AM.

PLoS One. 2013 Jul 3;8(7):e67897. doi: 10.1371/journal.pone.0067897. Print 2013.

PMID:
23844121
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[Treatment of systemic lupus erythematosus: myths, certainties and doubts].

Ruiz-Irastorza G, Danza A, Khamashta M.

Med Clin (Barc). 2013 Dec 21;141(12):533-42. doi: 10.1016/j.medcli.2013.02.014. Epub 2013 Apr 23. Review. Spanish.

PMID:
23622892
[PubMed - indexed for MEDLINE]
15.

[Belimumab in systemic lupus erythematosus: a guide for its use in the daily practice].

Ramos-Casals M, Ruiz-Irastorza G, Jiménez-Alonso J, Khamashta MA; Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Espa˜nola de Medicina Interna (SEMI).

Rev Clin Esp (Barc). 2013 Jan-Feb;213(1):66-7. Spanish. No abstract available.

PMID:
23565550
[PubMed - indexed for MEDLINE]
16.

Managing lupus nephritis in pregnant women: comment on the article by Hahn et al.

Ruiz-Irastorza G, Petri M, Gordon C, Khamashta M.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1391-2. doi: 10.1002/acr.22004. No abstract available.

PMID:
23495074
[PubMed - indexed for MEDLINE]
17.

Cancer risk in systemic lupus: an updated international multi-centre cohort study.

Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, Edworthy S, Jacobsen S, Gordon C, Dooley MA, Peschken CA, Hanly JG, Alarcón GS, Nived O, Ruiz-Irastorza G, Isenberg D, Rahman A, Witte T, Aranow C, Kamen DL, Steinsson K, Askanase A, Barr S, Criswell LA, Sturfelt G, Patel NM, Senécal JL, Zummer M, Pope JE, Ensworth S, El-Gabalawy H, McCarthy T, Dreyer L, Sibley J, St Pierre Y, Clarke AE.

J Autoimmun. 2013 May;42:130-5. doi: 10.1016/j.jaut.2012.12.009. Epub 2013 Feb 12.

PMID:
23410586
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Lymphoma risk in systemic lupus: effects of disease activity versus treatment.

Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin JF, Costenbader KH, Urowitz MB, Gladman DD, Fortin PR, Nived O, Petri MA, Jacobsen S, Manzi S, Ginzler EM, Isenberg D, Rahman A, Gordon C, Ruiz-Irastorza G, Yelin E, Bae SC, Wallace DJ, Peschken CA, Dooley MA, Edworthy SM, Aranow C, Kamen DL, Romero-Diaz J, Askanase A, Witte T, Barr SG, Criswell LA, Sturfelt GK, Blanco I, Feldman CH, Dreyer L, Patel NM, St Pierre Y, Clarke AE.

Ann Rheum Dis. 2014 Jan;73(1):138-42. doi: 10.1136/annrheumdis-2012-202099. Epub 2013 Jan 8.

PMID:
23303389
[PubMed - indexed for MEDLINE]
19.

[Recommendations on the use of belimumab in systemic lupus erythematosus. GEAS-SEMI Clinical Practice Guide].

Ramos-Casals M, Ruiz-Irastorza G, Jiménez-Alonso J, Khamashta MA; Comité de Consenso sobre el uso de belimumab, Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna (SEMI).

Rev Clin Esp (Barc). 2013 Jan-Feb;213(1):42-58. doi: 10.1016/j.rce.2012.10.004. Epub 2012 Dec 22. Spanish.

PMID:
23266125
[PubMed - indexed for MEDLINE]
20.

Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.

Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Bruce IN.

Ann Rheum Dis. 2013 Aug;72(8):1308-14. doi: 10.1136/annrheumdis-2012-202106. Epub 2012 Sep 3. Erratum in: Ann Rheum Dis. 2014 Jan;73(1):320.

PMID:
22945501
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk